We selected ERBB2, GRB7 and ONECUT2 for validation due to their importance in the biology of breast cancer, the magnitude of the change found in the RNA-seq data analysis and the consistency between the European and IA ancestry analyses. Here, ERBB2 is linked to breast carcinoma.